Literature DB >> 17604783

Cell therapy in myocardial infarction.

Harald Arnesen1, Ketil Lunde2, Svend Aakhus2, Kolbjørn Forfang2.   

Abstract

Entities:  

Mesh：

Year:  2007        PMID： 17604783     DOI： 10.1016/S0140-6736(07)60992-1

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  10 in total

Review 1.  Emerging roles for integrated imaging modalities in cardiovascular cell-based therapeutics: a clinical perspective.

Authors:  Peter J Psaltis; Robert D Simari; Martin Rodriguez-Porcel
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-09-08       Impact factor: 9.236

2.  Bone marrow cell therapy after acute myocardial infarction. Back to bench, or ready for an outcome trial.

Authors:  Ketil Lunde
Journal:  J Cardiovasc Transl Res       Date:  2008-11-14       Impact factor: 4.132

Review 3.  Oxygen and oxygenation in stem-cell therapy for myocardial infarction.

Authors:  Mahmood Khan; Pawel Kwiatkowski; Brian K Rivera; Periannan Kuppusamy
Journal:  Life Sci       Date:  2010-06-28       Impact factor: 5.037

4.  Cell distribution after intracoronary bone marrow stem cell delivery in damaged and undamaged myocardium: implications for clinical trials.

Authors:  Virginie F Forest; Ashok M Tirouvanziam; Christian Perigaud; Sarah Fernandes; Marion S Fusellier; Jean-Claude Desfontis; Claire S Toquet; Marie-Françoise M Heymann; Dominique P Crochet; Patricia F Lemarchand
Journal:  Stem Cell Res Ther       Date:  2010-03-15       Impact factor: 6.832

Review 5.  Cell therapy in myocardial infarction: emphasis on the role of MRI.

Authors:  Yuxiang Ye; Jan Bogaert
Journal:  Eur Radiol       Date:  2007-10-09       Impact factor: 5.315

6.  Cell therapy for ischaemic heart disease: focus on the role of resident cardiac stem cells.

Authors:  S A J Chamuleau; K R Vrijsen; D G Rokosh; X L Tang; J J Piek; R Bolli
Journal:  Neth Heart J       Date:  2009-05       Impact factor: 2.380

Review 7.  Cardiac cell repair therapy: a clinical perspective.

Authors:  Bernard J Gersh; Robert D Simari; Atta Behfar; Carmen M Terzic; Andre Terzic
Journal:  Mayo Clin Proc       Date:  2009-10       Impact factor: 7.616

8.  Long-term effects of autologous bone marrow stem cell treatment in acute myocardial infarction: factors that may influence outcomes.

Authors:  David M Clifford; Sheila A Fisher; Susan J Brunskill; Carolyn Doree; Anthony Mathur; Mike J Clarke; Suzanne M Watt; Enca Martin-Rendon
Journal:  PLoS One       Date:  2012-05-24       Impact factor: 3.240

Review 9.  Discrepancies in autologous bone marrow stem cell trials and enhancement of ejection fraction (DAMASCENE): weighted regression and meta-analysis.

Authors:  Alexandra N Nowbar; Michael Mielewczik; Maria Karavassilis; Hakim-Moulay Dehbi; Matthew J Shun-Shin; Siana Jones; James P Howard; Graham D Cole; Darrel P Francis
Journal:  BMJ       Date:  2014-04-28

Review 10.  Bone marrow mononuclear stem cells: potential in the treatment of myocardial infarction.

Authors:  Anne-Laure Leblond; John O'Sullivan; Noel Caplice
Journal:  Stem Cells Cloning       Date:  2009-12-04
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.